Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vimentin Antibody [VIM66-1] | Login | Vimentin Antibody [VIM66-1] | ||||||||||||||||
|
||||||||||||||||||
| PCNA Antibody [PM441-1] | Login | PCNA Antibody [PM441-1] | ||||||||||||||||
|
||||||||||||||||||
| CD31 Antibody [PCM25-1] | Login | CD31 Antibody [PCM25-1] | ||||||||||||||||
|
||||||||||||||||||
| CD68 Antibody [LAM34-1] | Login | CD68 Antibody [LAM34-1] | ||||||||||||||||
|
||||||||||||||||||
| CD44 Antibody [HCM15-1] | Login | CD44 Antibody [HCM15-1] | ||||||||||||||||
|
||||||||||||||||||
| GFAP Antibody [GFA12-3] | Login | GFAP Antibody [GFA12-3] | ||||||||||||||||
|
||||||||||||||||||
| EpCAM Antibody [EPM17-1] | Login | EpCAM Antibody [EPM17-1] | ||||||||||||||||
|
||||||||||||||||||
| p53 Antibody [CTA53-1] | Login | p53 Antibody [CTA53-1] | ||||||||||||||||
|
||||||||||||||||||
| Prostate Specific Antibody [PSAK3-1] | Login | Prostate Specific Antibody [PSAK3-1] | ||||||||||||||||
|
||||||||||||||||||
| HCG-alpha Antibody [CGA91-2] | Login | HCG-alpha Antibody [CGA91-2] | ||||||||||||||||
|
||||||||||||||||||
| Melan-A Antibody [MRT3V] | Login | Melan-A Antibody [MRT3V] | ||||||||||||||||
|
||||||||||||||||||
| CD5 Antibody [CLDA5-1] | Login | CD5 Antibody [CLDA5-1] | ||||||||||||||||
|
||||||||||||||||||
| EGFR Antibody [ERB7-1] | Login | EGFR Antibody [ERB7-1] | ||||||||||||||||
|
||||||||||||||||||
| HCG-beta Antibody [CGB63] | Login | HCG-beta Antibody [CGB63] | ||||||||||||||||
|
||||||||||||||||||
| c-Myc Antibody [MVH39-1] | Login | c-Myc Antibody [MVH39-1] | ||||||||||||||||
|
||||||||||||||||||
| Mitochondrial Antibody [MTL56] | Login | Mitochondrial Antibody [MTL56] | ||||||||||||||||
|
||||||||||||||||||
| VEGFR1 Antibody [VGR1T-1] | Login | VEGFR1 Antibody [VGR1T-1] | ||||||||||||||||
|
||||||||||||||||||
| Complement 4d Antibody [CPT4d-1] | Login | Complement 4d Antibody [CPT4d-1] | ||||||||||||||||
|
||||||||||||||||||
| MUC-1 Antibody [MCN01-1] | Login | MUC-1 Antibody [MCN01-1] | ||||||||||||||||
|
||||||||||||||||||
| Glypican-3 Antibody [SGPN3-1] | Login | Glypican-3 Antibody [SGPN3-1] | ||||||||||||||||
|
||||||||||||||||||
| CD6 Antibody [CLDA6-1] | Login | CD6 Antibody [CLDA6-1] | ||||||||||||||||
|
||||||||||||||||||
| ODC Antibody [ORN255-1] | Login | ODC Antibody [ORN255-1] | ||||||||||||||||
|
||||||||||||||||||
| AMPD3 Antibody [ETAD3-1] | Login | AMPD3 Antibody [ETAD3-1] | ||||||||||||||||
|
||||||||||||||||||
| CD45RB Antibody [CDLA45RB-1] | Login | CD45RB Antibody [CDLA45RB-1] | ||||||||||||||||
|
||||||||||||||||||
| IgM Antibody [MuHC2] | Login | IgM Antibody [MuHC2] | ||||||||||||||||
|
||||||||||||||||||


